Article Information
History
- December 8, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jayendrakishore Tanjore Ramanathan1,
- Suvi Lehtipuro2,
- Harri Sihto1,3,
- József Tóvári4,
- Lilla Reiniger5,6,
- Vanda Téglási6,
- Judit Moldvay5,7,
- Matti Nykter2,8,
- Hannu Haapasalo9,
- Vadim Le Joncour1 and
- Pirjo Laakkonen1,10,*
- 1Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Finland
- 2Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
- 3Clinicum, Faculty of Medicine, University of Helsinki, Finland
- 4Department of Experimental Pharmacology, National Institute of Oncology, Budapest, Hungary
- 5SE-NAP Brain Metastasis Research group, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary
- 61st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- 7Department of Tumor Biology, National Korányi Institute of Pulmonology–Semmelweis University, Budapest, Hungary
- 8Science Center, Tampere University Hospital, Tampere, Finland
- 9Department of Pathology, University of Tampere and Fimlab laboratories, Tampere, Finland
- 10Laboratory Animal Centre, HiLIFE – Helsinki Institute of Life Science, University of Helsinki, Finland
- ↵*Corresponding author: Prof. Pirjo Laakkonen, Translational Cancer Medicine Research Program, Haartmaninkatu 8, 00014 University of Helsinki, Finland. pirjo.laakkonen{at}helsinki.fi